Singapore: Japan-based global analytics technology provider, Shimadzu (Asia Pacific), has launched i-Series of new indus...
Singapore: China's HUYA Bioscience has struck a partnership with Changzhou Center for Biotech Development (CZCBD) to foc...
Singapore: Australia based drug development company, CSL, has secured the necessary approvals required to proceed with t...
Singapore: Australia-based Bionomics has initiated a Phase 1b clinical trial in healthy volunteers of BNC210, the drug c...
Singapore: The US Food and Drug Administration has formed an internal task force that will support the development of ne...
Singapore: In a bid to boost drug pipeline, Gilead Sciences has acquired Farnesoid X Receptor (FXR) program comprising s...
Singapore: Global bio pharmaceutical company, Merck Sharp and Dohme, has received USFDA nod to review the supplemental b...
Singapore: A Chinese biotech firm, Chipscreen Biosciencees has received the China FDA nod for its flagship drug Epidaza ...
Singapore: Australian drug development company, Invion, has completed the enrolment in its phase II clinical trial of IN...
Singapore: Nature Biotechnology has published a peer-reviewed paper co-authored by the Biotechnology Industry Organizati...
Singapore: Clinical research company, CPR Pharma Services, launched a new laboratory, in Adelaide, Australia, to provide...
Singapore: The US Food and Drug Administration (FDA) has approved Genentech's Perjeta for people with her2-positive met...
Singapore: Monash Institute of Pharmaceutical Sciences (MIPS) has been recognised for the Monash-GSK Australian Centre f...
Singapore: National Institutes of Health (NIH) Clinical Center has suspended operations of its Pharmaceutical Developmen...
Singapore: Researchers at the National Institutes of Health (NIH) have identified a potential new drug that could help i...
Singapore: Alexion pharma has announced the submission of New Drug Application (NDA) to the Japanese Ministry of Health,...
Singapore: Japanese pharma major Takeda Pharmaceutical Company has announced that the randomized, double-blind, placebo-...
Singapore: A phase II interim analysis of a randomized study involving Boehringer Ingelheim's investigational haematolog...
